MY144530A - Biologically non-degradable peptides, angiotensin converting enzyme inhibitors, drug and functional food - Google Patents

Biologically non-degradable peptides, angiotensin converting enzyme inhibitors, drug and functional food

Info

Publication number
MY144530A
MY144530A MYPI20044653A MY144530A MY 144530 A MY144530 A MY 144530A MY PI20044653 A MYPI20044653 A MY PI20044653A MY 144530 A MY144530 A MY 144530A
Authority
MY
Malaysia
Prior art keywords
pro
peptides
functional food
drug
converting enzyme
Prior art date
Application number
Inventor
Naoyuki Yamamoto
Seiichi Mizuno
Shingo Nishimura
Takanobu Gotou
Keiichi Matsuura
Original Assignee
Calpis Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Calpis Co Ltd filed Critical Calpis Co Ltd
Priority to MYPI20044653 priority Critical patent/MY144530A/en
Publication of MY144530A publication Critical patent/MY144530A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

THE PRESENT INVENTION PROVIDES NOVEL IN VIVO INDIGESTIBLE PEPTIDES THAT ARE HIGHLY ABSORBABLE AND HARDLY DIGESTIBLE IN LIVING ORGANISM WHEN ADMINISTERED ORALLY OR THROUGH OTHER ROUTE, AND EXPECTED TO EFFECTIVELY EXHIBIT FUNCTIONS, SUCH AS HYPOTENSIVE EFFECT, IN LIVING ORGANISM, AND ACE INHIBITORS PREPARED WITH THE PEPTIDES, AND MEDICINE OR FUNCTIONAL FOOD EXPECTED TO EFFECTIVELY EXHIBIT HYPOTENSIVE EFFECT IN LIVING ORGANISM. THE IN VIVO INDIGESTIBLE PEPTIDES ARE DIPEPTIDES ORTRIPEPTIDES HAVING PRO AT THE CARBOXYL TERMINALS, SELECTED FROM THE GROUP CONSISTING OF GLN-PRO,MET-PRO, AND SER-PRO-PRO.
MYPI20044653 2004-11-09 2004-11-09 Biologically non-degradable peptides, angiotensin converting enzyme inhibitors, drug and functional food MY144530A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI20044653 MY144530A (en) 2004-11-09 2004-11-09 Biologically non-degradable peptides, angiotensin converting enzyme inhibitors, drug and functional food

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI20044653 MY144530A (en) 2004-11-09 2004-11-09 Biologically non-degradable peptides, angiotensin converting enzyme inhibitors, drug and functional food

Publications (1)

Publication Number Publication Date
MY144530A true MY144530A (en) 2011-09-30

Family

ID=45491126

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20044653 MY144530A (en) 2004-11-09 2004-11-09 Biologically non-degradable peptides, angiotensin converting enzyme inhibitors, drug and functional food

Country Status (1)

Country Link
MY (1) MY144530A (en)

Similar Documents

Publication Publication Date Title
TW200507869A (en) In vivo indigestible peptide, angiotensin-converting enzyme inhibitor, medicine, and functional food
EP2364716A3 (en) Compositions and methods for the treatment of natural killer cell related diseases
NZ707292A (en) Activin-actrii antagonists and uses for increasing red blood cell levels
EP2322202A3 (en) Compositions and methods for the treatment of immune diseases
JP2009084294A5 (en)
ITRM20020596A0 (en) IMPLANT VASCULAR PROSTHESIS WITH COMBINED TECHNIQUE, LAPAROSCOPIC AND ENDOVASCULAR, FOR THE TREATMENT OF ABDOMINAL AORTA ANEURYSMS, AND CO.
EP2182006A3 (en) Compositions and methods for the treatment of immune related diseases
AU2003210300A1 (en) The use of tnf-alpha antagonist as drugs for the treatment of patients with sepsis and without suffering from total organ failure
EP1875924A3 (en) RGD-enriched gelatine-like proteins for prevention of platelet aggregation
EA200601904A1 (en) SYSTEM OF EXTENDED GRINDING OF MEDICINES BASED ON POLYMERS
NZ576467A (en) Smoothened polypeptides and methods of use
NZ602471A (en) Antagonists of activin-actriia and uses for increasing red blood cell levels
EP2517721A3 (en) Treatment of T-cell mediated diseases
EP2112161A3 (en) Peptides that lower blood glucose levels
WO2004043474A3 (en) Use of one or more elements from the group containing yttrium, neodymium and zirconium
MXPA05000880A (en) Probiotics for gut neuromuscular functions.
BR9607336A (en) Amino acid compositions and their uses in clinical nutrition
GEP20074211B (en) Novel perindopril salt and pharmaceutical compositions containing same
PL365246A1 (en) Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions
PL1622939T3 (en) Active variants of the il-18 binding protein and medical uses thereof
DK1599215T3 (en) Use of tryptophan-rich peptides from milk protein hydrolyzate to treat obesity and obesity
EP2392336A3 (en) Use of 24-norUDCA
GEP20063821B (en) Orodispersible pharmaceutical composition comprising perindopril
WO2004016741A3 (en) Prenylation inhibitors containing dimethyl-cyclobutane and methods of their synthesis and use
WO2010057275A8 (en) Cyclic peptides and uses thereof